NervGen Pharma Corp. (NGEN)
2.00
+0.14
(+7.53%)
USD |
NASDAQ |
Aug 24, 16:00
2.03
+0.03
(+1.50%)
After-Hours: 07:49
NervGen Pharma Total Assets (Quarterly) : 63.57M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.57M |
| March 31, 2026 | 14.88M |
| December 31, 2025 | 16.93M |
| September 30, 2025 | 9.399M |
| June 30, 2025 | 12.40M |
| March 31, 2025 | 11.00M |
| December 31, 2024 | 13.55M |
| September 30, 2024 | 16.62M |
| June 30, 2024 | 20.38M |
| March 31, 2024 | 23.49M |
| December 31, 2023 | 10.04M |
| September 30, 2023 | 12.10M |
| June 30, 2023 | 13.16M |
| March 31, 2023 | 14.11M |
| December 31, 2022 | 17.62M |
| Date | Value |
|---|---|
| September 30, 2022 | 21.02M |
| June 30, 2022 | 10.07M |
| March 31, 2022 | 11.12M |
| December 31, 2021 | 14.17M |
| September 30, 2021 | 7.403M |
| June 30, 2021 | 7.021M |
| March 31, 2021 | 5.019M |
| December 31, 2020 | 5.240M |
| September 30, 2020 | 7.673M |
| June 30, 2020 | 4.500M |
| March 31, 2020 | 3.813M |
| December 31, 2019 | 5.217M |
| September 30, 2019 | 5.332M |
| June 30, 2019 | 6.846M |
| March 31, 2019 | 7.303M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 9.134M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Clearmind Medicine, Inc. | 14.52M |
| Lexaria Bioscience Corp. | 4.781M |
| Target Group, Inc. (Canada) | 5.678M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.39M |
| Shareholders Equity (Quarterly) | 12.18M |
| Current Ratio | 1.232 |
| Net Debt Paydown Yield | 0.01% |